ArticleJournal of clinical medicine2021

Long-Term Efficacy and Safety of Ibrutinib in the Treatment of CLL Patients: A Real Life Experience.

Alessandro Broccoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.